UK Opioid Drug Manufacturer Paid Record $1.4 Billion to Stop Investigations and Obtain Immunity Deal

Pixabay
image_pdfimage_print
Reckitt Benckiser (RB Group) agreed to pay $1.4 billion to resolve US investigations over claims that its former pharmaceuticals business, Indivior carried out an illegal scheme to boost sales of an opioid addiction treatment. Indivior was accused of deceiving doctors into believing its product, Suboxone Film, itself a form of opioid, was safer and less susceptible to abuse than similar opioid drugs, and the company allegedly directed opioid-addicted patients to doctors who prescribed Suboxone at high rates. Indivior has pleaded not guilty to conspiracy and fraud charges and will face trial in federal court.

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment.

The settlement, the largest by any company related to the U.S. opioid epidemic, resolved long-running probes by the U.S. Justice Department and the Federal Trade Commission into the companies’ marketing and sales of Suboxone Film.

The deal came after Indivior in April was indicted and accused of deceiving doctors and healthcare benefit programs into believing Suboxone Film, itself a form of opioid, was safer and less susceptible to abuse than similar drugs.

The indictment said Indivior also used an internet and telephone program touted as a resource for opioid-addicted patients to connect them to doctors it knew were prescribing Suboxone and other opioids at high rates and in suspect circumstances.

Read full article here…

Additional source:

https://www.zerohedge.com/news/2019-07-12/drugmaker-pays-largest-opioid-settlement-history-make-investigations-go-away

Related Post

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary

Classifieds

For classified advertising rates and terms, click here. The appearance of ads on this site does not signify endorsement by the publisher. We do not attempt to verify the accuracy of statements made therein or vouch for the integrity of advertisers. However, we will investigate complaints from readers and remove any message we find to be misleading or that promotes anything fraudulent, illegal, or unethical.

1
Leave a Reply

avatar
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
0 Comment authors
Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
trackback
UK Opioid Drug Manufacturer Paid Record $1.4 Billion to Stop Investigations and Obtain Immunity Deal | WeAreChangeTV.US

[…] 15, 2019 Reuters No Comments This post was originally published on this […]